A Phase I-II Study of Postoperative Capecitabine-Based Chemoradiotherapy in Gastric Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 5, 2007, Pages 1424-1428

  Jansen, Edwin P M ^a   Boot, Henk ^a   Saunders, Mark P ^b   Crosby, Tom D L ^c   Dubbelman, Ria ^a   Bartelink, Harry ^a   Verheij, Marcel ^a   Cats, Annemieke ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c VELINDRE CANCER CENTRE   (United Kingdom)

Author keywords

Capecitabine; Chemoradiotherapy; Gastric cancer; Phase I II study; Toxicity

Indexed keywords

CHEMOTHERAPY; DOSIMETRY; RADIOTHERAPY; TOXICITY;

CAPECITABINE; GASTRIC CANCER; LOCOREGIONAL CONTROL;

TUMORS;

CAPECITABINE; FLUOROURACIL;

ADULT; AGED; ANASTOMOSIS; ANEMIA; ANOREXIA; ARTICLE; BLOOD TOXICITY; CANCER CONTROL; CANCER PATIENT; CANCER SURVIVAL; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG SAFETY; DRUG TOLERABILITY; DRY SKIN; DYSPHAGIA; EPILEPSY; ESOPHAGEAL ADENOCARCINOMA; FATIGUE; FEASIBILITY STUDY; FEMALE; GASTROINTESTINAL TOXICITY; HAND FOOT SYNDROME; HOARSENESS; HUMAN; INDIGESTION; JAW PAIN; KERATITIS; KERATITIS ACTINICA; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MAXIMUM TOLERATED DOSE; MONOTHERAPY; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROTOXICITY; NEUTROPENIA; PAIN; PERICARDITIS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; RETROSTERNAL PAIN; SIDE EFFECT; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMATITIS; SWEATING; TASTE DISORDER; THROMBOCYTOPENIA; TREATMENT PLANNING; TREMOR; VOMITING; WEIGHT REDUCTION;

ADENOCARCINOMA; ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; ESOPHAGOGASTRIC JUNCTION; FEASIBILITY STUDIES; FEMALE; FLUOROURACIL; HUMANS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; RADIOTHERAPY DOSAGE; STOMACH NEOPLASMS;

EID: 36149001338     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.05.004     Document Type: Article

References (27)

1. Jansen E., Boot H., Verheij M., et al. Optimal locoregional treatment in gastric cancer. J Clin Oncol 23 (2005) 4509-4517
2. Hundahl S.A., Phillips J.L., and Menck H.R. The National Cancer Database report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis. Cancer 88 (2000) 921-932
3. Wanebo H.J., Kennedy B.J., Chmiel J., et al. Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg 218 (1993) 583-592
4. Cuschieri A., Weeden S., Fielding J., et al. Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 79 (1999) 1522-1530
5. Hartgrink H.H., van de Velde C.J., Putter H., et al. Extended lymph node dissection for gastric cancer: Who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22 (2004) 2069-2077
6. Earle C.C., and Maroun J.A. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: Revisiting a meta-analysis of randomised trials. Eur J Cancer 35 (1999) 1059-1064
7. Gianni L., Panzini I., Tassinari D., et al. Meta-analyses of randomized trials of adjuvant chemotherapy in gastric cancer. Ann Oncol 12 (2001) 1178-1180
8. Hermans J., Bonenkamp J.J., Boon M.C., et al. Adjuvant therapy after curative resection for gastric cancer: Meta-analysis of randomized trials. J Clin Oncol 11 (1993) 1441-1447
9. Janunger K.G., Hafstrom L., and Glimelius B. Chemotherapy in gastric cancer: A review and updated meta-analysis. Eur J Surg 168 (2002) 597-608
10. Mari E., Floriani I., Tinazzi A., et al. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: A meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). Ann Oncol 11 (2000) 837-843
11. Cunningham D., Allum W.H., Stenning S.P., et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355 (2006) 11-20
12. Allum W.H., Hallissey M.T., Ward L.C., et al. A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: Interim report. British Stomach Cancer Group. Br J Cancer 60 (1989) 739-744
13. Macdonald J.S., Smalley S.R., Benedetti J., et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345 (2001) 725-730
14. Evans T.R., Pentheroudakis G., Paul J., et al. A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable oesophago-gastric adenocarcinoma. Ann Oncol 13 (2002) 1469-1478
15. Hoff P.M., Ansari R., Batist G., et al. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: Results of a randomized phase III study. J Clin Oncol 19 (2001) 2282-2292
16. Greene F.L. AJCC Cancer Staging Manual. 6th ed. (2002), Springer-Verlag, New York
17. Bernier J., Domenge C., Ozsahin M., et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350 (2004) 1945-1952
18. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340 (1999) 1144-1153
19. Schaake-Koning C., van den Bogaert W., Dalesio O., et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326 (1992) 524-530
20. Bosset J.F., Collette L., Calais G., et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355 (2006) 1114-1123
21. Rodel C., Grabenbauer G.G., Papadopoulos T., et al. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol 21 (2003) 3098-3104
22. Vaishampayan U.N., Ben Josef E., Philip P.A., et al. A single-institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies. Int J Radiat Oncol Biol Phys 53 (2002) 675-679
23. Cunningham D., Rao S., Starling N., et al. Randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer: The REAL 2 trial. J Clin Oncol 24 Suppl. (2006) 18S
24. Wagner A.D., Grothe W., Haerting J., et al. Chemotherapy in advanced gastric cancer: A systematic review and meta-analysis based on aggregate data. J Clin Oncol 24 (2006) 2903-2909
25. Jansen E.P.M., Saunders M.P., Boot H., et al. Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer. Int J Radiat Oncol Biol Phys 67 (2007) 781-785
26. Verheij M, Oppedijk V, Boot H, et al. Late renal toxicity following post-operative chemoradiotherapy in gastric cancer [abstract 2]. Proceedings of the American Society of Clinical Oncology-Gastrointestinal Cancers Symposium, Miami, FL, 27-29 January 2005.
27. Randomized phase III trial of adjuvant chemotherapy or chemoradiotherapy in resectable gastric cancer (CRITICS). Available at: http://www.clinicaltrials.gov/ct/show/NCT00407186 2007. Accessed June 8, 2007.